The listing gain is adjusted upward from a 0% GMP baseline due to exceptional financial quality (ROE > 50%) and a small float size creating a scarcity squeeze. However, the gain is capped by a complete lack of institutional QIB demand (0.0x) and a neutral overall review.
💪 Strengths
Exceptional ROE of 51.53% and ROCE of 45.73%
Low leverage with Debt-to-Equity ratio of 0.19
Strong PAT growth from ₹3.58Cr to ₹8.65Cr in one year
⚠️ Weaknesses
Lack of institutional (QIB) interest in the current subscription profile
Small scale of operations compared to industry giants like Sheela Foam
🚀 Opportunities
Expansion of manufacturing capacity through IPO proceeds
Growth potential in the organized mattress and home comfort market
🛡️ Threats
Intense competition from established brands and new-age D2C players
Volatility in raw material prices for polyurethane foam
🎯 Objectives of the IPO
Requirement / Purpose
Amount (₹ Cr)
To finance the Capital expenditure requirements for civil construction and purchase of Machineries and Equipments for existing manufacturing facility
₹13.72
To part finance the requirement of Working Capital
This issue is managed by Hem Securities Ltd., and Share India Capital Services Pvt. Ltd.
Disclaimer: The information provided on this page is for educational and informational purposes only and does not constitute financial advice. IPO investments are subject to market risks. AI-generated analysis is based on publicly available data and may not be accurate. Grey Market Premium (GMP) is unofficial and highly speculative. Always consult a qualified financial advisor and read the DRHP/RHP carefully before making investment decisions.